Cushing's Disease & Non-Functioning Hypothalamic-Pituitary Tumours

OR42-1

Pituitary MRI findings in patients with pituitary and ectopic ACTH –dependent Cushing syndrome: Can inferior petrosal sinus sampling (IPSS) be avoided?
Divya Yogi-Morren, Mouhammed Amir Habra, Charles Faiman, Betul Ayse Hatipoglu, Laurence Kennedy, Robert J Weil and Amir Hekmat Hamrahian

OR42-2

Does Prolactin Measurement Improve Lateralization during IPSS in Patients with Cushing's Disease?
Susmeeta T. Sharma, Hershel Raff, Russell R Lonser, Edward Hudson Oldfield and Lynnette Kaye Nieman

OR42-3

Changes in corticotroph tumor size and plasma ACTH levels in Cushing's disease (CD) patients during long-term treatment with the glucocorticoid antagonist mifepristone (MIFE)
Maria Fleseriu, James W. Findling, Christian A. Koch, Sven-Martin Schlaffer, Michael Buchfelder and Coleman Gross

OR42-4

Clinical, metabolic, biochemical and radiological characterisation of patients with thyrotropinomas reveals a highly variable phenotype
Olympia Koulouri, Narayanan Kandasamy, Carla M Moran, David Halsall, V Krishna K Chatterjee and Mark Gurnell

OR42-5

Pituitary Adenomas due to Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations: Genotypic-Phenotypic Characteristics, Screening and Prospective Diagnosis
Laura C. Hernández-Ramírez, Plamena Gabrovska, Judit Dénes, Giampaolo Trivellin, Scott Alexander Akker, Ashley B. Grossman, Mônica Gadelha, Márta Korbonits and The International FIPA Consortium

OR42-6

Xanthogranuloma, Rathke‘s cyst, and Childhood Craniopharyngioma – Results of Prospective Multinational Studies of Children and Adolescents with Rare Sellar Malformations
Hermann Lothar Muller, Ursel Gebhardt, Andreas Faldum, Monika Warmuth-Metz, Torsten Pietsch, Fabian Pohl and Gabriele Calaminus